Free Trial

Aimei Health Technology (AFJK) Competitors

Aimei Health Technology logo
$34.89 +1.88 (+5.70%)
As of 10:42 AM Eastern
This is a fair market value price provided by Massive. Learn more.

AFJK vs. GATE, TINV, BRRR, LAND, and MBAV

Should you buy Aimei Health Technology stock or one of its competitors? MarketBeat compares Aimei Health Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aimei Health Technology include Marblegate Acquisition (GATE), Tiga Acquisition (TINV), CoinShares Valkyrie Bitcoin Fund (BRRR), Gladstone Land (LAND), and M3-Brigade Acquisition V (MBAV). These companies are all part of the "trading" industry.

How does Aimei Health Technology compare to Marblegate Acquisition?

Marblegate Acquisition (NASDAQ:GATE) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marblegate Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Marblegate Acquisition has a beta of -0.5, meaning that its share price is 150% less volatile than the broader market. Comparatively, Aimei Health Technology has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

In the previous week, Aimei Health Technology had 1 more articles in the media than Marblegate Acquisition. MarketBeat recorded 1 mentions for Aimei Health Technology and 0 mentions for Marblegate Acquisition. Aimei Health Technology's average media sentiment score of 1.87 beat Marblegate Acquisition's score of 0.00 indicating that Aimei Health Technology is being referred to more favorably in the news media.

Company Overall Sentiment
Marblegate Acquisition Neutral
Aimei Health Technology Very Positive

Marblegate Acquisition's return on equity of 0.00% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Marblegate AcquisitionN/A N/A N/A
Aimei Health Technology N/A -33.32%2.91%

9.4% of Marblegate Acquisition shares are held by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are held by institutional investors. 71.2% of Marblegate Acquisition shares are held by company insiders. Comparatively, 2.5% of Aimei Health Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marblegate AcquisitionN/AN/A-$2.39MN/AN/A
Aimei Health TechnologyN/AN/A$1.06M$0.18193.84

Summary

Aimei Health Technology beats Marblegate Acquisition on 7 of the 9 factors compared between the two stocks.

How does Aimei Health Technology compare to Tiga Acquisition?

Aimei Health Technology (NASDAQ:AFJK) and Tiga Acquisition (NYSE:TINV) are both small-cap trading companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Aimei Health Technology has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market. Comparatively, Tiga Acquisition has a beta of -0.02, meaning that its stock price is 102% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Tiga Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

45.6% of Aimei Health Technology shares are held by institutional investors. Comparatively, 54.5% of Tiga Acquisition shares are held by institutional investors. 2.5% of Aimei Health Technology shares are held by company insiders. Comparatively, 4.5% of Tiga Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Aimei Health Technology had 1 more articles in the media than Tiga Acquisition. MarketBeat recorded 1 mentions for Aimei Health Technology and 0 mentions for Tiga Acquisition. Aimei Health Technology's average media sentiment score of 1.87 beat Tiga Acquisition's score of 0.00 indicating that Aimei Health Technology is being referred to more favorably in the media.

Company Overall Sentiment
Aimei Health Technology Very Positive
Tiga Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aimei Health TechnologyN/AN/A$1.06M$0.18193.84
Tiga AcquisitionN/AN/A$23.19MN/AN/A

Aimei Health Technology's return on equity of -33.32% beat Tiga Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Aimei Health TechnologyN/A -33.32% 2.91%
Tiga Acquisition N/A -36.88%-2.91%

Summary

Aimei Health Technology beats Tiga Acquisition on 6 of the 9 factors compared between the two stocks.

How does Aimei Health Technology compare to CoinShares Valkyrie Bitcoin Fund?

CoinShares Valkyrie Bitcoin Fund (NASDAQ:BRRR) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap trading companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

CoinShares Valkyrie Bitcoin Fund's return on equity of 0.00% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
CoinShares Valkyrie Bitcoin FundN/A N/A N/A
Aimei Health Technology N/A -33.32%2.91%

45.6% of Aimei Health Technology shares are owned by institutional investors. 2.5% of Aimei Health Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CoinShares Valkyrie Bitcoin Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, CoinShares Valkyrie Bitcoin Fund had 1 more articles in the media than Aimei Health Technology. MarketBeat recorded 2 mentions for CoinShares Valkyrie Bitcoin Fund and 1 mentions for Aimei Health Technology. Aimei Health Technology's average media sentiment score of 1.87 beat CoinShares Valkyrie Bitcoin Fund's score of -0.04 indicating that Aimei Health Technology is being referred to more favorably in the news media.

Company Overall Sentiment
CoinShares Valkyrie Bitcoin Fund Neutral
Aimei Health Technology Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CoinShares Valkyrie Bitcoin FundN/AN/AN/AN/AN/A
Aimei Health TechnologyN/AN/A$1.06M$0.18193.84

CoinShares Valkyrie Bitcoin Fund has a beta of 2.03, indicating that its share price is 103% more volatile than the broader market. Comparatively, Aimei Health Technology has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market.

Summary

Aimei Health Technology beats CoinShares Valkyrie Bitcoin Fund on 5 of the 8 factors compared between the two stocks.

How does Aimei Health Technology compare to Gladstone Land?

Gladstone Land (NASDAQ:LAND) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap trading companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

In the previous week, Gladstone Land had 1 more articles in the media than Aimei Health Technology. MarketBeat recorded 2 mentions for Gladstone Land and 1 mentions for Aimei Health Technology. Aimei Health Technology's average media sentiment score of 1.87 beat Gladstone Land's score of 1.27 indicating that Aimei Health Technology is being referred to more favorably in the news media.

Company Overall Sentiment
Gladstone Land Positive
Aimei Health Technology Very Positive

Gladstone Land has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market. Comparatively, Aimei Health Technology has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market.

Gladstone Land presently has a consensus target price of $10.00, suggesting a potential upside of 11.42%. Given Gladstone Land's stronger consensus rating and higher probable upside, research analysts plainly believe Gladstone Land is more favorable than Aimei Health Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Gladstone Land
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.25
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Gladstone Land has higher revenue and earnings than Aimei Health Technology. Gladstone Land is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gladstone Land$88.34M4.38$13.53M-$0.61N/A
Aimei Health TechnologyN/AN/A$1.06M$0.18193.84

Aimei Health Technology has a net margin of 0.00% compared to Gladstone Land's net margin of -6.68%. Gladstone Land's return on equity of -0.87% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Gladstone Land-6.68% -0.87% -0.48%
Aimei Health Technology N/A -33.32%2.91%

53.6% of Gladstone Land shares are owned by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are owned by institutional investors. 6.1% of Gladstone Land shares are owned by company insiders. Comparatively, 2.5% of Aimei Health Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Gladstone Land beats Aimei Health Technology on 10 of the 15 factors compared between the two stocks.

How does Aimei Health Technology compare to M3-Brigade Acquisition V?

Aimei Health Technology (NASDAQ:AFJK) and M3-Brigade Acquisition V (NASDAQ:MBAV) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Aimei Health Technology has a beta of 0.22, suggesting that its share price is 78% less volatile than the broader market. Comparatively, M3-Brigade Acquisition V has a beta of 0.12, suggesting that its share price is 88% less volatile than the broader market.

M3-Brigade Acquisition V's return on equity of 0.00% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Aimei Health TechnologyN/A -33.32% 2.91%
M3-Brigade Acquisition V N/A N/A N/A

In the previous week, M3-Brigade Acquisition V had 2 more articles in the media than Aimei Health Technology. MarketBeat recorded 3 mentions for M3-Brigade Acquisition V and 1 mentions for Aimei Health Technology. Aimei Health Technology's average media sentiment score of 1.87 beat M3-Brigade Acquisition V's score of 0.62 indicating that Aimei Health Technology is being referred to more favorably in the media.

Company Overall Sentiment
Aimei Health Technology Very Positive
M3-Brigade Acquisition V Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aimei Health TechnologyN/AN/A$1.06M$0.18193.84
M3-Brigade Acquisition VN/AN/AN/AN/AN/A

45.6% of Aimei Health Technology shares are held by institutional investors. 2.5% of Aimei Health Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
M3-Brigade Acquisition V
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Aimei Health Technology beats M3-Brigade Acquisition V on 5 of the 7 factors compared between the two stocks.

Get Aimei Health Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFJK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFJK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFJK vs. The Competition

MetricAimei Health TechnologyUNCLASSIFIED IndustryFinancial SectorNASDAQ Exchange
Market Cap$110.47M$172.95M$5.95B$12.31B
Dividend YieldN/AN/A5.29%5.66%
P/E Ratio193.8444.8116.4324.76
Price / SalesN/A14,506.071,736.68168.32
Price / Cash66.2158.1948.6737.92
Price / Book-18.2738.696.586.90
Net Income$1.06M-$19.43M$1.13B$337.45M
7 Day Performance-11.98%-2.06%1.57%2.84%
1 Month Performance-17.47%1.70%2.01%4.78%
1 Year PerformanceN/A7.34%21.03%33.08%

Aimei Health Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFJK
Aimei Health Technology
0.8885 of 5 stars
$34.89
+5.7%
N/AN/A$110.46MN/A193.83N/A
GATE
Marblegate Acquisition
N/A$36.05
flat
N/AN/A$417.53MN/AN/A3
TINV
Tiga Acquisition
N/A$11.47
-0.9%
N/A-49.4%$395.72MN/AN/AN/A
BRRR
CoinShares Valkyrie Bitcoin Fund
N/A$17.96
+0.1%
N/A-39.7%$395.08MN/AN/AN/A
LAND
Gladstone Land
1.7315 of 5 stars
$8.95
-0.5%
$10.00
+11.7%
-11.5%$386.25M$88.09MN/A70

Related Companies and Tools


This page (NASDAQ:AFJK) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners